Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Wall Street surges to five-year highs; Dow ends above 14,000

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2013 | 10:39pm CEST

Stocks rose to five-year highs on Friday, with the Dow closing above 14,000 for the first time since October 2007, after jobs and manufacturing data showed the economy's recovery remains on track.

The S&P touched its highest since December 2007 after a 5 percent gain in January, which was its best start to a year since 1997. The index is now just about 60 points away from its all-time intraday high of 1,576.09.

Employment grew modestly in January, with 157,000 jobs added. That was slightly below expectations, but Labor Department revisions showed 127,000 more jobs were created in November and December than previously reported.

Analysts attributed the market's robust showing so far this year partly to a deluge of cash flowing into equities.

Investors poured $12.7 billion into U.S.-based stock mutual funds and exchange-traded funds in the latest week, concluding the strongest four-week flows into stock funds since 1996, data showed on Thursday.

"There is a lot of money looking for a home, and people are finally deciding the bond market is done and moving money into equities," said Edward Simmons, managing director and partner at HighTower in Portland, Maine.

"I see the rotation (of assets) pushing the market up in the face of not-massive amounts of good news," he said. "People are overlooking the higher risk in equities."

Other reports released Friday showed the pace of growth in the U.S. manufacturing sector picked up in January to its highest level in nine months, U.S. consumer sentiment rose more than expected last month, while December construction spending also beat forecasts.

"All the data seems to keep pointing to a slowly, steadily improving economy," said Eric Kuby, chief investment officer at North Star Investment Management Corp in Chicago.

The Dow Jones industrial average <.DJI> was up 149.21 points, or 1.08 percent, at 14,009.79. The Standard & Poor's 500 Index <.SPX> was up 15.06 points, or 1.01 percent, at 1,513.17. The Nasdaq Composite Index <.IXIC> was up 36.97 points, or 1.18 percent, at 3,179.10.

With the day's gains, major equity indexes rose five straight weeks.

More than 600 stocks on the NYSE and the Nasdaq combined hit 52-week highs on Friday, including Google <GOOG.O.> which rose as high as $776.60, before closing at $775.60, up 2.6 percent.

Investors were also attuned to corporate earnings, with a trio of Dow components reporting profits that beat expectations.

Exxon Mobil (>> Exxon Mobil Corporation) ended flat at $90.04 after reporting results while Chevron (>> Chevron Corporation) added 1.2 percent to $116.50.

Drugmaker Merck & Co (>> Merck & Co., Inc.) fell 3.3 percent to $41.83 after a cautious 2013 outlook.

Generic drugmaker Perrigo (>> Perrigo Company) reported a better-than-expected second-quarter profit and its shares jumped 4.7 percent to $105.28.

Of the 252 companies in the S&P 500 that have reported earnings so far, 69 percent have exceeded expectations, according to Thomson Reuters data. That is a higher proportion than over the past four quarters and above average since 1994.

Overall, S&P 500 fourth-quarter earnings are estimated to have grown 4.4 percent, according to the data, up from a 1.9 percent forecast at the start of the earnings season but well below a 9.9 percent profit growth forecast on October 1.

Dell Inc (>> Dell Inc.) gained 2.9 percent to $13.63 after sources said the company was nearing an agreement to sell itself to a buyout consortium led by its founder, Michael Dell, and private equity firm Silver Lake Partners.

(Reporting By Angela Moon; Editing by Kenneth Barry)

By Angela Moon

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERRIGO COMPANY
08/25 PERRIGO : to Acquire U.S. Distributor of Healthcare & Consumer Goods Products, G..
08/24 PERRIGO COMPANY PLC : ex-dividend day
08/18 PERRIGO : Learn how to target a 20% return on Tesla Motors, or get option-trade ..
08/18 PERRIGO : Drug maker acquiring distributor
08/15 PERRIGO COMPANY PLC : Post Earnings Coverage as Perrigo Doubles Profit
08/15DJStada Arzneimittel Braced for Investor Battle
08/10 PERRIGO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
08/10 SunPower and Perrigo skid while Disney and Yelp climb
08/10 S&P 500 MOVERS : Prgo, rl
08/10DJU.S. HOT STOCKS : Hot Stocks to Watch
More news
Sector news : Pharmaceuticals - NEC
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
08/26DJALERE : Sues Abbott to Force Merger -- 2nd Update
More sector news : Pharmaceuticals - NEC
Advertisement
Financials ($)
Sales 2016 5 410 M
EBIT 2016 1 430 M
Net income 2016 414 M
Debt 2016 5 106 M
Yield 2016 0,56%
P/E ratio 2016 67,38
P/E ratio 2017 25,82
EV / Sales 2016 3,29x
EV / Sales 2017 3,01x
Capitalization 12 696 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus HOLD
Number of Analysts 20
Average target price 109 $
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Hendrickson President, Chief Executive Officer & Director
Mary Lauren Brlas Chairman
Judy L. Brown Executive VP, Chief Financial & Accounting Officer
Thomas Farrington Chief Information Officer & Executive VP
Gerald K. Kunkle Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY12 696
JOHNSON & JOHNSON15.89%325 679
ROCHE HOLDING LTD.-11.47%214 671
PFIZER INC.7.87%211 206
NOVARTIS AG-9.62%210 234
ASTRAZENECA PLC7.33%173 797
More Results